Corrigendum for Yu et al.,
ERRATA |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
References |
|---|
1. Parkin, D. M., P. Pisani, and J. Ferlay. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 54: 594-606 [Medline].
2. Valaitis, J., S. Warren, and D. Gamble. 1981. Increasing incidence of adenocarcinoma of the lung. Cancer 41: 1042-1046 .
3. Minna, J. D., H. Pass, E. Glastein, and D. C. Ihde. 1989. Carcinoma of the lung. In V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg, editors. Cancer: Principles and Practice of Oncology. J. B. Lippincott, Philadelphia. 591-703.
4. Sagawa, M., Y. Saito, S. Takahashi, K. Usuda, K. Kamma, M. Sato, S.-I. Ota, N. Nagamoto, S. Fujimura, T. Nakada, K. Hashimoto, H. Suda, T. Imai, and H. Saito. 1990. Clinical and prognostic assessment of patients with resected small peripheral lung cancer lesions. Cancer 66: 2653-2657 [Medline].
5. Devereux, T. R., J. A. Taylor, and J. C. Barrett. 1996. Molecular mechanisms of lung cancer: interaction of environmental and genetic factors. Chest 109(Suppl.): 14S-19S [Medline].
6. World Health Organization. 1982. The World Health Organization histological typing of lung tumors. Am. J. Clin. Pathol 1982: 123-136 .
7.
Itzkowitz, S. H.,
E. J. Bloom,
W. A. Kokal,
G. Modin,
S. Hakomori, and
Y. S. Kim.
1990.
Sialyl-Tn
a novel mucin antigen associated with
prognosis in colorectal carcinoma patients.
Cancer
66:
1960-1966
[Medline].
8. McGuckin, M. A., M. D. Walsh, B. G. Hohn, B. G. Ward, and R. G. Wright. 1995. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum. Pathol 26: 432-439 [Medline].
9. Devine, P. L., and I. F. C. McKenzie. 1992. Mucins: structure, function and associations with malignancy. Bioessays 14: 619-625 [Medline].
10. Kawai, T., M. Suzuki, K. Kase, and Y. Ozeki. 1993. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 72: 1581-1587 [Medline].
11.
Orawa, J.-I.,
A. Sano,
S. Koide, and
A. Shohtsu.
1994.
Relation between
recurrence and expression of proliferating cell nuclear antigen, sialyl
Lewisx, and sialyl Lewisa in lung cancer.
J. Thorac. Cardiovasc. Surg
108:
329-336
12. Mountain, C. F. 1986. A new international staging system for lung cancer. Chest 89(Suppl. 4):225-233.
13.
Harpole, D. H.,
J. E. Herndon,
W. G. Wolfe,
J. D. Iglehart, and
J. R. Marks.
1995.
A prognostic model of recurrence and death in stage I
non-small-cell lung cancer utilizing presentation, histopathology, and
oncoprotein expression.
Cancer Res
55:
51-56
14. Xerri, L., M.-J. Payan, R. Choux, N. Gros, D. Figarella-Branger, and H. Sarles. 1990. Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions. Hum. Pathol 21: 927-931 [Medline].
15. Glantz, S. A. 1987. Primer of Biostatics, 2nd ed. McGraw-Hill, New York. 101-137.
16. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc 53: 457-481 .
17. Cox, D. R.. 1972. Regression Models and life tables. J. R. Stat. Soc. (Series B) 34: 187-200 .
18. Linnoila, R. I., S. Piantadosi, and J. C. Ruckdeschel. 1994. Impact of neuroendocrine differentiation in non-small-cell lung carcinoma: the LCSG experience. Chest 106(Suppl.): 367S-371S [Medline].
19.
Graziano, S. L.,
A. H. Tatum,
N. B. Newman,
A. Oler,
L. J. Kohman,
L. J. Veit,
G. P. Gamble,
M. J. Coleman,
S. Barmada, and
S. O'Lear.
1994.
The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small-cell lung cancer.
Cancer Res
54:
2908-2913
20. Clayton, F.. 1986. Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer 57: 1555-1564 [Medline].
21.
Correa, P..
1988.
A human model of gastric carcinogenesis.
Cancer Res
48:
3554-3560
22. Allen, D. C., N. S. Connolly, and J. D. Biggart. 1988. High iron diamine-alcian blue mucin profiles in benign, premalignant and malignant colorectal disease. Histopathology 13: 399-411 [Medline].
23.
Otaga, S.,
P. J. Maimonis, and
S. H. Itzkowitz.
1992.
Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
Cancer Res
52:
4741-4746
24. Gendler, S. J., and A. P. Spicer. 1995. Epithelial mucin genes. Annu. Rev. Physiol 57: 607-634 [Medline].
25. Hilkens, J., M. J. L. Lightenberg, H. L. Vos, and S. V. Litvinov. 1992. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci 17: 359-363 [Medline].
26.
Charest, M. P., and
J. Roth.
1985.
Localization of sialic acid in kidney
glomeruli: regionalization in the podocyte plasma membrane and loss
in experimental nephrosis.
Proc. Natl. Acad. Sci. U.S.A
82:
8508-8512
27. Ho, J. J. L., S. Chang, and Y. S. Kim. 1995. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem. Biophys. Res. Commun 210: 866-873 [Medline].
28. Yogeeswaran, G.. 1982. Cell membrane glycolipids and glycoproteins in malignant transformation. Adv. Cancer Res 38: 289-350 .
29. Petrick, A. T., S. Meterissian, G. Steele Jr., and P. Thomas. 1994. Desialylation of human colorectal carcinoma cells facilitates binding to Kupffer cells. Clin. Exp. Metastasis 12: 108-116 [Medline].
30. Kakari, S., E. Stringou, M. Toumbis, A. S. Ferderigos, E. Poulaki, K. Chondros, A. Dema, V. Kotsovoulou, and N. Pavlidis. 1991. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid. Anticancer Res 11: 2107-2110 [Medline].
31. Thomas, P.. 1996. Cell surface sialic acid as a mediator of metastatic potential in colorectal cancer. Cancer J 9: 32-36 .
32.
Kern, J. A.,
D. A. Schwartz,
J. E. Nordberg,
D. B. Weiner,
M. Greene II,
L. Torney, and
R. A. Robinson.
1990.
p185neu expression in human
lung adenocarcinomas predicts shortened survival.
Cancer Res
50:
5184-5191
33.
Wu, K.,
N. Fregein, and
K. L. Carraway.
1994.
Molecular cloning and sequencing of the mucin subunit of a heterodimeric, bifunctional cell
surface glycoprotein complex of ascites rat mammary adenocarcinoma cells.
J. Biol. Chem
269:
11950-11955
34. Satoh, K., H. Sasano, T. Shimosegawa, M. Koizumi, T. Yamazaki, F. Mochizuki, N. Kobayashi, T. Okano, T. Toyota, and T. Sawai. 1993. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer 72: 51-56 [Medline].
35. Carbone, D. P., T. Mitsudomi, I. Chiba, S. Piantadosi, V. Rusch, J. A. Nowak, D. McIntyre, D. Slamon, A. Gazdar, and J. Minna. 1994. P53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: a preliminary report of LCSG 871. Chest 106(Suppl.): 377S-381S [Medline].
| ||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |